Chronic Hepatitis C Virus and the Hispanic Community: Cultural Factors Impacting Care

Gastroenterology Nursing

Volumn 27, Issue 5, 2004, Pages 230-238

  Stevenson, Lani ^a   Faucher, Yvonne ^a   Hewlett, Sandra ^a   Klemm, Karen ^a   Nelson, Deborah ^a  

^a METHODIST DALLAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; COMMUNICATION DISORDER; DEMOGRAPHY; EDUCATION; ETHNOLOGY; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH SERVICE; HEPATITIS C; HISPANIC; HUMAN; LANGUAGE; MASS SCREENING; MORTALITY; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PREVALENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; STANDARD; TOTAL QUALITY MANAGEMENT; TRANSCULTURAL CARE; UNITED STATES;

COMMUNICATION BARRIERS; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS C, CHRONIC; HISPANIC AMERICANS; HUMANS; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; SOCIOECONOMIC FACTORS; TOTAL QUALITY MANAGEMENT; TRANSCULTURAL NURSING; TRANSLATING; UNITED STATES;

EID: 16544394465     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200409000-00006     Document Type: Article

References (25)

1. Aguirre-Molina, M., Ramirez, A., Ramirez, M. (1993). Health promotion and disease prevention strategies. Public Health Reports, 108, 559-564.
2. Alter, M.J., & Mast, E.E. (1994). The epidemiology of viral hepatitis in the United States. Gastroenterology Clinics of North America, 23, 437-455.
3. nd ed.)(pp. 177-237). Pittsburgh, PA: Oncology Nursing Society.
4. Davis, G.L., Esteban-Mur, R., Rustgi, V., et al. (1998). Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Group. New England Journal of Medicine, 339, 1493-1499.
5. Doak, C., Doak, L., Friedell, G., & Meade, C. (1998). Improving comprehension for cancer patients with low literacy skills: Strategies for clinicians. CA: A Cancer Journal for Clinicians, 48, 151-162.
6. Ellis, C. (1998). Cultural issues and the Hispanic oncology patient. Nursing Interventions in Oncology, 10, 2-4.
7. Hibbeln, J. (1999). Special populations: Hispanic migrant workers. In S. Torres (Ed.). Hispanic voices: Hispanic health educators speak out (pp. 162-192). New York, NY: National League for Nursing.
8. Hoffmann-LaRoche (2002). Pegasys [complete product information]. Nutley, NJ: Hoffmann-LaRoche Inc.
9. Hoffmann-LaRoche, Inc. (2003). Roferon-A [prescribing information]. Nutley, NJ: Hoffmann-LaRoche Inc.
10. InterMune, Inc. (2003). Infergen [prescribing information]. Brisbane, CA: InterMune, Inc.
11. Kagawa-Singer, M. (1997). Addressing issues for early detection and screening in ethnic populations. Oncology Nursing Forum, 24, 1705-1706.
12. Latino Organization for Liver Awareness (LOLA). (1999). Hepatitis C and the Latino community (brochure(. New York, NY: Latino Organization for Liver Awareness.
13. Lipson, J.G., Dibble, S.L., Minarik, P.A. (Eds.). (1996). Culture and nursing care: A pocket guide (pp. 64-73, 82-100, 203-238). San Francisco, CA: UCSF Nursing Press.
14. Manns, M.P., McHutchison, J.G., Gordon, S.C., et al. (2001). Peg interferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet, 358, 958-965.
15. McHutchison, J.G., Gordon, S.C., Schiff, E.R., et al. (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Intervention Therapy Group. New England Journal of Medicine, 339, 1485-1492.
16. Murphy, S.L. (July 24, 2000). Deaths: Final data for 1998. National Vital Statistics Reports, 48 (11):37. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
17. National Institutes of Health (NIH). (2002) National Institutes of Health consensus development conference panel statement. Management of Hepatitis C: 2002. Bethesda, MD: National Institutes of Health.
18. Neff, N. (n.d.) Folk medicine in Hispanics in the Southwestern United States. In Health status and determinants of health of Hispanic populations, Module VII [online course(. Available at:. Accessed September 3, 2003.
19. Novello, A.C., Soto-Torres, L.E. (1993). One voice, one vision—uniting to improve Hispanic-Latino health. Public Health Reports, 108, 529-533.
20. Schering Corporation. (2002a). Intron® A [prescribing information]. Kenilworth, NJ: Schering Corp.
21. Schering Corporation. (2002b). REBETRON Combination Therapy [product information]. Kenilworth, NJ: Schering Corp.
22. Schering Corporation. (2003). PEG-Intron® [product information]. Kenilworth, NJ: Schering Corp.
23. Therrien, M., & Ramirez, R.R. (March 2001). The Hispanic population in the United States: March 2000. Current Population Reports P20-535. Washington, DC: U.S. Department of Commerce, Bureau of the Census.
24. Valdez, R., Giachello, A., Rodriguez-Trias, H., Gomez, P., de la Rocha, C. (1993). Improving access to healthcare in Latino communities. Public Health Report, 108, 534-539.
25. Zambrana, R.E., & Dorrington, C. (1998). Economic and social vulnerability of Latino children and families by subgroup: Implications for child welfare. Child Welfare, 77, 5-27.